ALBANY, N.Y. (NEWS10) — Thrash metal band Overkill will be blasting into Albany for a spring performance at Empire Live. The concert is set for March 26 at 8 p.m. Best known for their songs ...

Sometimes it takes a combination of building pressures to spark a landslide of positive change. For pharmaceutical giant Bristol Myers Squibb (BMS), the moment came following its $74 billion ...

BMS is Harbour’s second powerhouse partner this year after the Chinese biotech signed a potential $4.68 billion deal with AstraZeneca in March. Bristol Myers Squibb is betting more than $1 billion for ...

Bristol Myers Squibb is securing an opportunity to compete in the next generation of cell therapies through the $1.5 billion acquisition of Orbital Therapeutics, a startup with a lead program nearing ...

Not ones to sit around and waste time, New Jersey’s very own thrash metal icons Overkill are back at the studio writing new music for their follow-up to 2023’s Scorched. Earlier this week, the band’s ...

Thrash metal stalwarts Overkill are wasting no time moving forward after a major lineup change. Just over a year since releasing Scorched, the New Jersey veterans are already writing and demoing ...

Beecher Manufacturing Services acquired BMS Manufacturing Co. in Watkins Glen, New York. The acquisition will help Ward Apparatus, another Beecher company, increase fire truck production. The ...

Sigvotatug vedotin (SV), an investigational integrin beta-6 (IB6)–directed antibody‒drug conjugate (ADC), and pembrolizumab combination therapy: Initial results from an ongoing phase 1 study ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...